Bioinformatics startup launches via tech company and hospital partnership

A new bioinformatics outfit has emerged. BioLinQ, a provider of biomedical informatics for disease diagnosis and medical research, was formed through a partnership between Transformatix Technologies and National Children's Hospital in Columbus, OH, News-Medical reports. "Years of development at Nationwide Children's Hospital funded in part by the National Institutes of Health have laid the foundation for very mature, high-end solutions in digital pathology, biospecimen analysis and biorepository management," said Ken Murray, founder and CEO, Transformatix Technologies, as quoted by News-Medical. "With the growth of molecular technology and the advent of personalized medicine, BioLinQ is poised to have a significant impact upon the diagnostic and research capabilities in hospitals, academic research centers and the pharmaceutical industry." Item

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.